Centre de Recherche Médicale de Lambaréné
Quick facts
Marketed products
Phase 2 pipeline
- Artefenomel-Ferroquine · Infectious Diseases
Artefenomel-Ferroquine is a combination of artefenomel and ferroquine, which targets the Plasmodium falciparum parasite. - artesunate-pyronaridine
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Centre de Recherche Médicale de Lambaréné portfolio CI brief
- Centre de Recherche Médicale de Lambaréné pipeline updates RSS
Frequently asked questions about Centre de Recherche Médicale de Lambaréné
What are Centre de Recherche Médicale de Lambaréné's marketed drugs?
Top marketed products include Benzimidazole Anthelmintic.